semaglutide and ibs-d Patients with stable inflammatory bowel disease (IBD) comorbid obesity and/or diabetes who started GLP-1 receptor agonists (semaglutide or tirzepatide) alongside ongoing treatment did not have a lower risk for the relapse Semaglutide, GLP-1 Drugs, and IBS:

Ro said it hopes its new tool can help patients understand their coverage options so they can decide how to pursue weight loss

Welcome to Pure Prescriptions I founded Pure Prescriptions after overcoming Cancer at age 29 , a battle that taught me the power of natural supplements and inspired me to make professional-grade, doctor-only brands accessible onlinepioneering the industry over 25 years ago

For instance, in April 2025, Pfizer, a US-based pharmaceutical company specializing in metabolic and cardiometabolic drug development, provided an update on its oral GLP-1 receptor agonist candidate, danuglipron, following the completion of once-daily formulation studies intended to improve dosing convenience for patients

Three months in, she describes measurable changes in skin texture, specifically reduced surface roughness and noticeably faster closure following a minor resurfacing procedure her dermatologist performed at week ten

A highly cited 2020 umbrella meta-analysis of 37 randomized controlled trials concluded that L-carnitine supplementation provides a modest but significant reducing effect on body weight, body mass index (BMI), and fat mass